QTXB — Quantrx Biomedical Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $1.58m
Annual balance sheet for Quantrx Biomedical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.46 | 0.322 | 0.13 | 0.055 | 0.006 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.891 | 0.36 | 0.137 | 0.055 | 0.006 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 1.39 | 0.582 | 0.137 | 0.055 | 0.006 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 2.14 | 2.09 | 2.27 | 2.44 | 2.65 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 2.14 | 2.09 | 2.27 | 2.44 | 2.65 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -0.75 | -1.51 | -2.13 | -2.38 | -2.64 |
Total Liabilities & Shareholders' Equity | 1.39 | 0.582 | 0.137 | 0.055 | 0.006 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |